<p>Tourmaline Bio Inc. has filed an initial statement of beneficial ownership, naming Novartis AG as the beneficial owner. The full filing can be accessed through the link below. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tourmaline Bio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-25-103023), on October 28, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here</p>

TRML

<p>Tourmaline Bio Inc. has filed an initial beneficial ownership statement, identifying Novartis AG as the beneficial owner. The filing is accessible via EDGAR, the SEC's system. This news was generated by Public Technologies and is for informational purposes only, not to be considered as financial or legal advice.</p>

Tourmaline Bio Inc. Files Initial Beneficial Ownership Statement Naming Novartis AG